Countable Certified Service Providers are certified by Countable Labs for demonstrated expertise using Countable PCR technology to support studies of all sizes
The 2026 list highlights the pharmaceutical companies, biotechnology firms and CRDMOs are advancing decarbonization, green manufacturing and sustainable operations
As sponsor–CRO collaborations become even more central to drug discovery, fragmented data and manual processes continue to slow progress – but more structured, connected workflows are beginning to reshape how teams share and act on information
Thermo Fisher Scientific and The Michael J. Fox Foundation expand the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource
In this guest editorial, Dr. Elena Sukhacheva, Director of Medical & Scientific Affairs, Beckman Coulter, explores how MPV helps laboratories deliver accurate diagnoses efficiently and maintain consistent, high-quality patient care
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximizing CHO cell productivity
Cambiotics’ co-founder Dr. Anna Lindell traces how PFAS move through the gut, and how microbes are fighting back
Single-vial cell mimic scatters and fluoresces with unmatched accuracy in compensation, viability, and spectral unmixing
Roche’s Donald Mason explains how automation, standardization, and core-lab integration could help clinical laboratories expand access to mass spectrometry-based testing
Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing, and streamline development of safer, more effective medicines
The multiplex PCR assay differentiates herpes simplex virus, varicella-zoster virus, and monkeypox virus in a single test
Real-world evidence registry for nonsegmental vitiligo to track long-term treatment outcomes and patient experiences
Kits help reduce complexity while improving consistency and turnaround time
Diana Vargas-Gold explains how optimized, patient-specific ddPCR assays could support ultra-sensitive liquid biopsy and minimal residual disease monitoring in laboratories
Verdel Instruments and the University of Warwick bring two-dimensional mass spectrometry (2DMS) to benchtop Q-TOF systems, expanding access to advanced molecular analysis
Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care
New AI-powered capabilities enable researchers to interact with laboratory knowledge, accelerate discovery, and generate scientific content directly within LabCollector
For decades, genomics led the journey from discovery to clinic — now, advances in proteomics are making a compelling case for a new leader
Azenta’s CoolCell™ enables alcohol-free, controlled-rate cell freezing for reproducible cryopreservation
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model
DeepCyte CEO Theodore Alexandrov explains how metabolomics and AI are advancing predictive toxicology, drug safety, and digital cell models
InstaFlux™ enables on-demand enrichment media preparation to streamline food microbiology testing workflows
University of Nottingham uses Genome Detective to replace slower Sanger-based workflows and complex bioinformatics pipelines
Restek redefines the benchmark for PFAS testing with 99.8% pure reference standards, long-term batch consistency, and a lab-driven portfolio
